Miho.Fukui
@Miho_Fukui_
Followers
513
Following
2K
Media
46
Statuses
807
Associate Scientific Director at Cardiovascular Imaging Research Center MHIF. Co-Developer of Redo-TAV App.
Minneapolis, MN
Joined August 2018
We just released Redo-TAV App all thanks to amazing contributors from the world🌎 This’s just start as this subject is growing everyday! Would appreciate for your any feedback🙏 iPhone: https://t.co/t3fJwkbkDJ Android: https://t.co/jNKlWdXtcY YouTubu:
apps.apple.com
The Redo TAV app provides guidelines for assessing the suitability of a transcatheter aortic valve for Redo-TAV procedures using systematic CT analysis (Redo-TAV CT planning) and provides procedural...
3
36
76
A “double-tap” strategy after balloon-expandable TAVI improved valve expansion without increasing procedural risk. In selected anatomies, this approach achieved greater stent expansion and remained safe at 30 days. @juliusjonas_ ; @JonathonLeipsic ; @sellers_steph ; @David_Meier_
1
23
62
Read our state-of-the-art review for an in-depth understanding of alternative access possibilities for #TAVR #JACCINT @feistritzerH_J
In this #JACCINT state-of-the-art review, read about choosing the right alternative access for #TAVR, balancing feasibility, safety & efficacy. https://t.co/ase6u9u5d6
#CardioX @thiele_holger @fjsawaya @KendraGrubb @Mo_A_W
1
12
31
Great news for those who have not yet submitted the abstracts! まだ投稿が済んでいない方は是非っ！
🗓 Deadline extended to 14 October! You’ve got a few extra days to share your work ! Don’t miss your chance to be part of #PCRTokyo next February. 📩 Submit your Scientific Abstracts, Clinical Cases or Late-Breaking Trials now and make your mark in Tokyo!
0
4
8
THL月例ウェビナー 「つながる！大動脈弁狭窄症診療：新時代の治療戦略」 10/20 19:00から、参加費無料！ 無症候性の大動脈弁狭窄症、どう診療してますか？ 1. EARLY-TAVR trialの経過観察群 2. 心エコーによる評価 3. MRI・CTを用いたmulti-modality 評価 https://t.co/GBYrdEDyFe
@PeatixJPより
tokyoheartlab20251020.peatix.com
大動脈弁狭窄症 (AS: aortic stenosis)の治療体系が、今大きく変わりつつあります。ASは進行性の疾患であり、症状出現後には急速な予後悪化が知られています。これま... powered by Peatix : More than a ticket.
0
6
14
Of course, I’m submitting now!
Deadline for the abstracts/clinical cases submission is approaching! Don't forget to submit to be part of the next edition of PCR Tokyo Valves 2026!! We are all waiting for you to join us😊 @didier_tchetche @dmylotte @PCRonline
0
0
2
Deadline for the abstracts/clinical cases submission is approaching! Don't forget to submit to be part of the next edition of PCR Tokyo Valves 2026!! We are all waiting for you to join us😊 @didier_tchetche @dmylotte @PCRonline
Discover why Dr. Juri Iwata, 🏆 2025 Best Scientific Abstract Award winner, believes that submitting to #PCRTokyo is such a valuable opportunity. ✨ Gain unique insights ✨ Present your work on an international stage ✨ Connect with a community of peers Don’t miss your chance to
1
4
9
Discover why Dr. Juri Iwata, 🏆 2025 Best Scientific Abstract Award winner, believes that submitting to #PCRTokyo is such a valuable opportunity. ✨ Gain unique insights ✨ Present your work on an international stage ✨ Connect with a community of peers Don’t miss your chance to
0
6
11
🇺🇸まで送っていただけるとのことで、今か今かと、心待ちにしています😆 坂本先生、お招き頂きありがとうございました🙏
1
0
9
No correlation between echo parameters and cardiac MRI fibrosis markers A key study reminding us: know your tools, play to their strengths!
Our latest paper is published from JASE. Using Deep learning to Predict Cardiovascular Magnetic Resonance Findings from Echocardiography Videos Threads 🧵 https://t.co/RZGehnZOdz
@ASE360 @David_Ouyang @SmidtHeart
1
2
15
Our latest paper is published from JASE. Using Deep learning to Predict Cardiovascular Magnetic Resonance Findings from Echocardiography Videos Threads 🧵 https://t.co/RZGehnZOdz
@ASE360 @David_Ouyang @SmidtHeart
5
12
43
Primary TR registry across 10 centers | @JACCJournals In high-risk surgery: ✅ Patho: flail 28%, billowing prolapse 61%, restricted 11% ✅ T-TEER=in-hospital🪦1.8%, TR red. to ≤2+ 83% ✅ NYHA⬆️ RV rev. remodeling@1Y👍 #Tricuspid #TEER #primaryTR
https://t.co/pAfkBQCWKA
1
14
56
Redo-TAV simulation using post-TAVR CT imaging performed at 30 days suggested higher redo-TAV feasibility in patients with bicuspid aortic valves compared with tricuspid aortic valves. https://t.co/QLZ1WRwPc1
#JACCINT #TAVR @bapat_savrtavr
0
16
60
Welcome to our May 14: a special #ChinaValve2025 issue of #JACCCaseReports @JACCJournals! See our articles with links below. https://t.co/4acX849mgX Full PDF here: https://t.co/D05WDTDonn Video summary here: https://t.co/7UnEp0SgwG Thank you our Associate Editor @Kentso987 and
0
6
16
Thank you to our editorial board, all our reviewers and @JACCJournals team and YOU - authors, for making this happen with outstanding papers. Truly humbled by your trust in #JACCCaseReports to publish your work and making this educational endeavor 🌎🌍🌏! @MinnowWalsh
🚨 Big news from #JACCCaseReports! We’re publishing new issues every single week—packed with fascinating clinical cases, sharp editorial insights, “how we did it” breakdowns, and more. Start exploring the latest issue here: https://t.co/RnYg1FQakP
@GilbertTangMD @MinnowWalsh
0
8
42
Join us tomorrow for the Cath Conference with Arif Khokhar @DrArifK! 🎙️Topic of Discussion: How to Optimize TAVR Techniques and Outcomes with Bench Testing 📆 7.30 AM (EST) - Tuesday, April 29, 2025 🔗 https://t.co/rIfNrxHoFO
@azeemlatib @AndreaScotti21
0
5
13
Looking forward to discussing how bench-testing can help #TAVR with a focus on: 🎯 Redo-TAVR 🎯 Coronary access 🎯 Leaflet modification Sharing the excellent work by colleagues @ABeneduceMD @David_Meier_ @myriam_akodad @Miho_Fukui_ @CurioJonathan @fra_giannini1 & many others!
Join us tomorrow for the Cath Conference with Arif Khokhar @DrArifK! 🎙️Topic of Discussion: How to Optimize TAVR Techniques and Outcomes with Bench Testing 📆 7.30 AM (EST) - Tuesday, April 29, 2025 🔗 https://t.co/rIfNrxHoFO
@azeemlatib @AndreaScotti21
1
5
14
📢 Registration is open for CT for PCI Course 3.0! 📢 Join us to learn about the latest in coronary CT-guided PCI through: 🗣️ Expert-led presentations ✋ Practical hands-on sessions 💬 Interactive live cases & more! Register: https://t.co/C9fkDzBsAm
0
4
6
A special thanks to our event partner, @Pie_Med_Imaging; course directors, Drs. @Miho_Fukui_ and @bapat_savrtavr; and guest faculty, @GilbertTangMD, Toby Rogers, and @TheLADoctor! Interested in attending future courses? Sign up to receive notifications: https://t.co/vjGFZbm41m
0
1
3